NCT00210119View on ClinicalTrials.gov

Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response

PHASE2TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 12, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

March 31, 2009

Conditions
Myeloid Leukemia, Chronic
Interventions
DRUG

Glivec

Trial Locations (7)

33076

Centre Hospitalier Universitaire de Bordeaux, Bordeaux

Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest, Bordeaux

69437

Hôpital Edouard Herriot, Lyon

75010

Hôpital Saint Louis, Paris

78150

Centre Hospitalier de Versailles, Le Chesnay

86000

Centre Hospitalier Universitaire de Poitiers, Poitiers

06200

Hôpital Archet, Nice

Sponsors

Lead Sponsor

Institut Bergonié

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Institut Bergonié

OTHER